Expert Speakers

2022 Speakers

Discover what fresh new speakers and returning KOLs will be presenting at the 2nd Annual mRNA-Based Therapeutics Summit in Boston this July.

PHARMA & INDUSTRY LEADERS
ACADEMIC LEADERS
LEADING SOLUTION PARTNERS

PHARMA & INDUSTRY LEADERS

Kathy Fernando

Kathy Fernando

VP, Head of Worldwide Research, Development and Medical Operations; Head of mRNA Scientific Planning

Pfizer

Rituparna Das

VP – COVID Vaccines

Moderna

Regis Gervier

Global Head mRNA Center of Excellence

Sanofi

Jane True

VP - mRNA Commercial Development

Pfizer

Jacob Becraft

Co-Founder & CEO

Strand Therapeutics

Gregory Fiore

CEO

Exacis Biotherapeutics

Jenny van Asbeck – van der Wijst

CEO

Mercurna

Pad Chivukula

Co-Founder, CSO & COO

Arcturus Therapeutics

Yusuf Erkul

CEO

Kernal Biologics

Linda Marban

CEO

Capricor Therapeutics

Nathaniel Wang

CEO & Co-Founder

Replicate Bioscience

John Marshall

Senior Director – Rare Disease

Moderna

Camille Bedrosian

CMO & Executive VP

Ultragenyx

Hao Chen

Global Head of Cell & Viral Drug Substance

GlaxoSmithKline

Danilo Casimiro

Danilo Casimiro

CSO

Sanofi Pasteur

Cristina Bruno

Program Manager - mRNA Technology Transfer

World Health Organization

Brett Leav

Head, Clinical Development; Public Health Vaccines

Moderna

Haig Aghajanian

Co-Founder & VP of Research

Capstan Therapeutics

Russell Johnson

VP – Formulation Research

RVAC Medicines

Viktor Lemgart

Research Fellow

Tidal Therapeutics – A Sanofi Company

Manmohan Singh

SVP - Pharmaceutical Sciences & Delivery Technologies

Beam Therapeutics

Pervin Anklesaria

Deputy Director - HIV Vaccines & Biologics

Bill & Melinda Gates Foundation

Prashant Nambiar

SVP - Research & Translational Development

Strand Therapeutics

Rachel Groppo

Director - Replicon Team Leader

The Janssen Pharmaceutical Companies of Johnson & Johnson

Arunan Kaliyaperumal

VP - Preclinical Biology

ReCode Therapeutics

Charles Cabral

Drug Substance Manufacturing; Technology & Tech Transfer Director

Arcturus Therapeutics

Jianmei Kochling

Senior Director - Analytical Development

mRNA Center of Excellence, Sanofi

Stephanie Prizzon

Head - Analytical Sciences mRNA Center of Excellence

Sanofi

Arun Kumar

Pre-clinical Vaccines Development Lead

Coalition for Epidemic Preparedness Innovations (CEPI)

Christopher Cheng

VP - Process Development & RNA Technology

Verve Therapeutics

Duccio Medini

R3 Program Director

Wellcome Leap

Venkat Krishnamurthy

Executive Director - Genetic Medicines

Eli Lilly

Husain Attarwala

Director & Head - Pharmacometrics & Clinical Pharmacology

Moderna

Vishal Khanderia

Senior Director – Supply Chain

Beam Therapeutics

Vittorio Sebastiano

Co-Founder & Scientific Advisory Board Chairman

Turn Biotechnologies

Yurong Guo

Associate Director - Analytical Development & QC

Arcturus Therapeutics

Jacob Moginot

Senior Scientist – LNP Formulation

Strand Therapeutics

Jeffrey Ulmer

Chief Scientific Advisor

Immorna Biotherapeutics

Metin Kurtoglu

Chief Operating Officer

Cartesian Therapeutics

Rachit Jain

Associate Director - mRNA Process Development

Tessera Therapeutics

Akhilesh Bhambhani

Senior Director - Biologics Drug Product Development; Tech Dev/Tech Ops

Ultragenyx Pharmaceutical

Brian Sullivan

Principal Scientist - Vaccines and Immunology

Arcturus Therapeutics

Daniel Shores

Partner

Rothwell Figg

Darshana Jani

Senior Director - Preclinical & Clinical Bioanalytical Sciences

Moderna

David Liston

Senior Scientist

ReCode Therapeutics

Dipendra Gyawali

Sr. Scientist

Moderna

Milos Miljkovic

CMO

Cartesian Therapeutics

Mohammad Safari

Head of Analytical Biochemistry

Seqirus

Muthiah (Mano) Manoharan

SVP - Innovation Chemistry

Alnylam Pharmaceuticals

Shigeki Miyake-Stoner

Director - R&D & Head - Technology

Replicate Bioscience

Yingxia Wen

Senior Director; Head of Discovery Research

Seqirus

ACADEMIC LEADERS

Ameya Kirtane

Instructor in Medicine

Brigham and Women’s Hospital

Daniel G. Anderson

Professor of Medical Engineering & Science; Harvard- MIT Division of Health Sciences & Technology; Koch Institute for Integrative Cancer Research

Massachusetts Institute of Technology

Hamideh Parhiz

Research Assistant Professor of Medicine

Perelman School of Medicine, University of Pennsylvania

Prashant Yadav

Professor & Senior Fellow

INSEAD & Centre for Global Development

Harris Makatsoris

Professor of Sustainable Manufacturing Systems

King’s College London

Kalina Paunovska

Co-Founder, Nava Therapeutics

Dahlman Lab

Kirill Afonin

Professor of Chemistry

University of North Carolina at Charlotte

Zoltán Kis

Assistant Professor

The University of Sheffield

Bowen Li

Assistant Professor

University of Toronto

Gaurav Sahay

Associate Professor

Oregon State University

L. James Lee

Emeritus Helen C. Kurtz Professor of Chemical & Biomolecular Engineering

The Ohio State University

Lior Zangi

Associate Professor of Cardiology; Genetics & Genomic Sciences

Icahn School of Medicine at Mount Sinai

LEADING SOLUTION PARTNERS

Mark van Eldijk

Principal Scientist - Nanomedicine Development & Manufacturing

Ardena

May Guo

VP - Business Development; Nucleic Acids

Arranta Bio

Samuel Clarke

Director - R&D

Precision NanoSystems

Sophia Shamsi

Research Analyst

Beacon Targeted Therapies

Carmen Ledesma-Feliciano

Clinical Device Specialist

PharmaJet

Darwin Asa

Market Development Manager

ThermoFisher Scientific

Joe Makowiecki

Director of Business Development, Enterprise Solutions

Cytiva

Tomas Kostelec

Product Manager, mRNA

BIA Separations

James A. Hayward

Chief Executive Officer

Applied DNA Sciences

Jenny England

Manager, Research & Development

ThermoFisher Scientific

Khaled Yamout

Senior Director - Quality Control

TriLink BioTechnologies

Mario Pulido

Senior BioPharma Applications Scientist

SCIEX

Norman Garceau

VP - Global R&D Technology

Curia

Pierre Cagtinol

Executive VP; Head – Manufacturing

Samsung Biologics

Shiv Krishnan

Head - External Innovation; Biologics R&D

Lonza AG

VIEW AGENDA